Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer
Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer
- Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer
Paul Gineste brings 25 years of experience in clinical development and strategy with leading international pharmaceutical and biotech companies. - Recently, Paul served as Vice President, Clinical Operations at Abivax, where he led the development of drug candidates from discovery through global Phase 3 programs.
- Paris, France, January 4, 2024 - Evexta Bio SA, a clinical-stage biotechnology company focused on developing first-in-class therapies in oncology, announces the appointment of Paul Gineste as Chief Development Officer (CDO), effective January 1, 2024.
- Scott Filosi, CEO of Evexta Bio, said: "I am delighted to welcome Paul as the new Chief Development Officer of Evexta Bio.